Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT03706742 · ClinicalTrials.gov registry record · NA
STOP HCC: Mailed HCV Treatment Outreach Program for HCC Prevention
A NA study, sponsored by University of Texas Southwestern Medical Center.
- Completed
- Registry status
- NA
- Development phase
- 12,386
- Enrollment target
NCT03706742: Completed NA study, sponsored by University of Texas Southwestern Medical Center.
NCT03706742 is a NA study that has completed, run by University of Texas Southwestern Medical Center. The registered enrollment target is 12,386 participants, above the 1,403-participant average among 58,714 other NA trials with a reported enrollment target (783% higher). According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT03706742, a NA study, has completed, sponsored by University of Texas Southwestern Medical Center.
- COMPLETED
- Registry status
- NA
- Development phase
- 12,386 participants
- Enrollment target
Study Summary
Aim 1: The investigators will conduct a randomized controlled trial comparing two strategies to promote HCV screening, follow-up testing, and treatment among baby-boomers (i.e. persons born between 1945-1965): inreach with electronic medical record alerts and provider education vs. combination of inreach and provider education plus mailed outreach and patient navigation. Aim 2: The investigators will evaluate patient navigation strategies to promote follow-up testing and treatment evaluation among non-baby boomer Parkland patients (i.e. born before 1945 or after 1965) who are either: a) HCV antibody positive but have not completed follow-up viral load testing or b) HCV viral load positive and who have not completed in-clinic treatment evaluation.
Primary Outcome
Proportion with HCV Ab within 3 months of randomization
Interventions
- BEHAVIORAL Mailed outreach
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 12,386 participants |
| Start Date | 2018-09-10 |
| Est. Completion | 2021-03-31 |
| Phase | NA |
What the finished NCT03706742 record still lists
NCT03706742 is an interventional study that assigns participants to a tested intervention. Its 12,386 participants enrollment target places it among the larger protocols in the corpus, above the 1,403-participant average among 58,714 other NA trials with a reported enrollment target (783% higher).
The record links to 0 conditions, and to 1 intervention - of which Mailed outreach is the first listed.
NCT03706742 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT03706742 about?
NCT03706742 is a clinical study titled "STOP HCC: Mailed HCV Treatment Outreach Program for HCC Prevention". Aim 1: The investigators will conduct a randomized controlled trial comparing two strategies to promote HCV screening, follow-up testing, and treatment among baby-boomers (i.e. persons born between 1945-1965): inreach with electronic medical record alerts and provider education vs. combination of in...
What is the current status of trial NCT03706742?
This trial is currently completed. It is a NA study. The enrollment target is 12,386 participants. The study started on 2018-09-10. Estimated completion is 2021-03-31.
What interventions are being tested in trial NCT03706742?
The interventions under investigation include: Mailed outreach (BEHAVIORAL).
Who is sponsoring clinical trial NCT03706742?
This trial is sponsored by University of Texas Southwestern Medical Center, which has 837 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
How this trial's enrollment target compares
Where NCT03706742's enrollment target sits among peer trials
12,386 14th of 2000 higher than 1,987 of 2,000 other NA trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other NA trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT04888832 · 12,500 participants · NA
The Effect of Work Requirements in SNAP in Virginia
- NCT05452941 · 12,500 participants
A Study to Learn About How 20-Valent Pneumococcal Conjugate Vaccine Works in a Real-world Setting
- NCT07069556 · 12,500 participants
ColoSense Post-Approval Study
- NCT01772771 · 12,000 participants
Molecular Testing for the MD Anderson Cancer Center Personalized Cancer Therapy Program
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI